| KRX SM Exchange | US Country |
Invizyne Technologies, Inc. is a synthetic biochemical company based in the United States, with its headquarters located in Monrovia, California. Founded in 2014, the company has been at the forefront of developing innovative platforms for the production of a wide range of chemicals. These include pharmaceuticals, fuels, materials, food additives, and novel compounds. Invizyne Technologies leverages advanced biocatalytic conversion processes, utilizing one or more enzymes in modules to achieve desired chemical transformations. This innovative approach allows for more efficient and environmentally friendly production methods compared to traditional chemical synthesis.
The SimplePath platform is Invizyne Technologies' flagship technology, designed to produce a diverse array of chemicals. This platform distinguishes itself by utilizing modular biocatalytic conversion processes. Each module within the platform consists of one or more enzymes that work synergistically to convert substrates into desired products. This approach facilitates the efficient production of pharmaceuticals, fuels, materials, food additives, and novel compounds, showcasing the company's versatility and innovation in the biochemical sector.